» Authors » Seiichiro Mine

Seiichiro Mine

Explore the profile of Seiichiro Mine including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 187
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiwasa T, Yoshida Y, Kubota M, Li S, Zhang B, Matsutani T, et al.
Med Int (Lond) . 2024 Jul; 4(5):45. PMID: 38983794
Numerous antibody biomarkers have been reported for cancer and atherosclerosis-related diseases. The major complications of atherosclerosis and diabetes mellitus (DM) are acute ischemic stroke (AIS), cardiovascular disease (CVD) and chronic...
2.
Zhang B, Zhang X, Ito M, Yajima S, Yoshida K, Ohno M, et al.
Int J Mol Sci . 2024 May; 25(9). PMID: 38732153
Inflammation is closely associated with cerebrovascular diseases, cardiovascular diseases, diabetes, and cancers, and it is accompanied by the development of autoantibodies in the early stage of inflammation-related diseases. Hence, it...
3.
Izumi M, Kobayashi K, Kajikawa S, Kanazawa K, Takayama Y, Iijima K, et al.
Epilepsia . 2023 Oct; 64(12):3294-3306. PMID: 37905469
Objective: Ictal direct current shifts (icDCs) and ictal high-frequency oscillations (icHFOs) have been reported as surrogate markers for better surgical outcomes in epilepsy surgery. icDCs have been classified into two...
4.
Namiki T, Takemoto M, Hayashi A, Yamagata H, Ishikawa T, Yokote K, et al.
BMC Endocr Disord . 2023 Oct; 23(1):239. PMID: 37904164
Background: Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. Methods: Serological identification of antigens...
5.
Tomiyoshi G, Nakamura R, Shinmen N, Yoshida Y, Mine S, Machida T, et al.
Front Med (Lausanne) . 2023 May; 10:1128921. PMID: 37228401
We previously identified growth arrest and DNA-damage-inducible gene 34 (GADD34) as a marker of ischemic stroke. In the present study, serum levels of anti-GADD34 antibodies were found to be significantly...
6.
Li S, Yoshida Y, Kubota M, Zhang B, Matsutani T, Ito M, et al.
Front Cardiovasc Med . 2023 Feb; 10:1042272. PMID: 36844744
Introduction: Autoantibodies against inflammatory cytokines may be used for the prevention of atherosclerosis. Preclinical studies consider colony-stimulating factor 2 (CSF2) as an essential cytokine with a causal relationship to atherosclerosis...
7.
Kubota M, Zhang B, Li S, Yoshida Y, Wang H, Adachi A, et al.
Med Int (Lond) . 2023 Jan; 3(1):4. PMID: 36699658
Autoantibodies can be used in the early diagnosis and treatment of atherosclerosis-related diseases. Using ProtoArray screening of samples from patients with atherosclerosis, the present study identified thiosulfate sulfurtransferase-like domain-containing 2...
8.
Kubota M, Yoshida Y, Kobayashi E, Matsutani T, Li S, Zhang B, et al.
Sci Rep . 2021 Nov; 11(1):21772. PMID: 34741085
The presence of disease-specific antigens and autoantibodies in the sera of patients with atherosclerosis-related diseases has been widely reported and is considered to result from inflammation of the arterial wall...
9.
Mikuni N, Usui N, Otsubo H, Kawai K, Kishima H, Maehara T, et al.
Neurol Med Chir (Tokyo) . 2021 Oct; 61(11):619-628. PMID: 34629353
This study investigated the number of epilepsy surgeries performed over time in Japan, and conducted a questionnaire survey of the Japan Neurosurgical Society (JNS) training program core hospitals to determine...
10.
Wang H, Lu H, Zhang X, Goto K, Kobayashi E, Yoshida Y, et al.
BMC Neurol . 2021 Jul; 21(1):274. PMID: 34243715
Background: Ischemic stroke, including transient ischemic attack (TIA) and acute-phase cerebral infarction (aCI), is a serious health problem in the aging society. Thus, this study aimed to identify TIA and...